ImmunoGen, Inc. (IMGN): Price and Financial Metrics
IMGN Price/Volume Stats
| Current price | $31.23 | 52-week high | $31.25 |
| Prev. close | $31.23 | 52-week low | $3.61 |
| Day low | $31.22 | Volume | 48,606,800 |
| Day high | $31.25 | Avg. volume | 8,778,325 |
| 50-day MA | $29.35 | Dividend yield | N/A |
| 200-day MA | $19.00 | Market Cap | 8.32B |
IMGN Stock Price Chart Interactive Chart >
ImmunoGen, Inc. (IMGN) Company Bio
Immunogen develops targeted anticancer therapeutics. The Company's ADC technology uses tumor-targeting antibodies to deliver an ImmunoGen cell-killing agent specifically to cancer cells. The company was founded in 1981 and is based in Waltham, Massachusetts.
IMGN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 5.15% |
| 3-year | 327.81% |
| 5-year | 471.98% |
| YTD | 5.33% |
| 2023 | 497.78% |
| 2022 | -33.15% |
| 2021 | 15.04% |
| 2020 | 26.35% |
| 2019 | 6.35% |
Continue Researching IMGN
Want to see what other sources are saying about ImmunoGen Inc's financials and stock price? Try the links below:ImmunoGen Inc (IMGN) Stock Price | Nasdaq
ImmunoGen Inc (IMGN) Stock Quote, History and News - Yahoo Finance
ImmunoGen Inc (IMGN) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...